Transgene S.A.
TNG.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -€19,295 | -€17,486 | -€16,485 | -€6,426 |
| Dep. & Amort. | €700 | €745 | €608 | €772 |
| Deferred Tax | €0 | €0 | €0 | €0 |
| Stock-Based Comp. | €0 | €0 | €0 | €296 |
| Change in WC | -€1,432 | €13,618 | -€2,865 | -€916 |
| Other Non-Cash | €1,842 | -€2,585 | €609 | -€10,736 |
| Operating Cash Flow | -€18,185 | -€5,708 | -€18,133 | -€17,010 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -€279 | -€1,062 | -€2,013 | -€1,265 |
| Net Acquisitions | €0 | €0 | €0 | €0 |
| Inv. Purchases | -€314 | -€131 | €0 | €0 |
| Inv. Sales/Matur. | €0 | -€567 | €0 | €35,976 |
| Other Inv. Act. | €0 | €0 | €567 | €17,938 |
| Investing Cash Flow | -€593 | -€1,760 | -€1,446 | €16,673 |
| Financing Activities | – | – | – | – |
| Debt Repay. | €0 | €0 | €0 | €0 |
| Stock Issued | €0 | -€158 | €0 | €0 |
| Stock Repurch. | €0 | €0 | €0 | €0 |
| Dividends Paid | €0 | €0 | €0 | €0 |
| Other Fin. Act. | €20,283 | €8,577 | €18,833 | €25,162 |
| Financing Cash Flow | €20,283 | €8,419 | €18,833 | €12,283 |
| Forex Effect | -€1,403 | €399 | €400 | €0 |
| Net Chg. in Cash | €102 | €1,350 | -€346 | €11,946 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | €16,670 | €15,320 | €15,666 | €3,720 |
| End Cash | €16,772 | €16,670 | €15,320 | €15,666 |
| Free Cash Flow | -€18,464 | -€6,770 | -€20,137 | -€18,275 |